Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + Cetuximab in Incurable SCCHN
NCT02101034Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2014
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Washington University School of Medicine. Started Jun 2014; status: completed.
02
Drugs
palbociclib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02101034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101034.